On what evidence-base do we recommend self-monitoring of blood glucose?
Abstract Self-monitoring of blood glucose (SMBG) has been considered one major breakthrough in diabetes therapy because, for the first time, patients were able to determine their blood glucose levels during daily life. It seems obvious that this must be of advantage to disease management and clinica...
Gespeichert in:
| Veröffentlicht in: | Diabetes research and clinical practice 2010-02, Vol.87 (2), p.150-156 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 156 |
|---|---|
| container_issue | 2 |
| container_start_page | 150 |
| container_title | Diabetes research and clinical practice |
| container_volume | 87 |
| creator | Kolb, Hubert Kempf, Kerstin Martin, Stephan Stumvoll, Michael Landgraf, Rüdiger |
| description | Abstract Self-monitoring of blood glucose (SMBG) has been considered one major breakthrough in diabetes therapy because, for the first time, patients were able to determine their blood glucose levels during daily life. It seems obvious that this must be of advantage to disease management and clinical outcome, but it has become a nightmare for those trying to provide evidence. Randomised controlled trials have yielded inconsistent results on a benefit of SMBG-based treatment strategies not only in type 2 but – surprisingly – also in type 1 and gestational diabetes. Despite this, SMBG is being considered indispensible in intensive insulin treatment, but is being debated for other clinical settings. When considering the non-RCT based reasons for recommending SMBG in type 1 and gestational diabetes it becomes apparent that the same reasons also apply to type 2 diabetes. |
| doi_str_mv | 10.1016/j.diabres.2009.10.014 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733906221</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0168822709004628</els_id><sourcerecordid>733906221</sourcerecordid><originalsourceid>FETCH-LOGICAL-c419t-ca8f147390e28001809ca18d3f1246824801974ca618f59b10a03feaf2e758ae3</originalsourceid><addsrcrecordid>eNqFkcFu1DAQhi0EareljwDyjVOWGSeb2BcqVEFBqtQDcLYce1y8JHGxk1Z9e5zuSkhcONkaffOP5hvG3iBsEbB9v9-6YPpEeSsAVKltAZsXbIOyE5UUonvJNoWTz_9TdpbzHgDautmdsFNUSrTYwoZd30788aeZOT0ER5OlqjeZuIv8kXgiG8eRJsczDb4a4xTmmMJ0x6Pn_RCj43fDYmOmy9fslTdDpovje85-fP70_epLdXN7_fXq401lG1RzZY302HS1AhISACUoa1C62qNoWikaCai6xpoWpd-pHsFA7cl4Qd1OGqrP2btD7n2KvxfKsx5DtjQMZqK4ZN3VJbsVAgu5O5A2xZwTeX2fwmjSk0bQq0K910eFelW4lovC0vf2OGHpR3J_u47OCnB5AKjs-RAo6WzDqs6FImzWLob_jvjwT4IdwhSsGX7RE-V9XNJUJGrUWWjQ39Y7rmcEBdC0QtZ_ANlHmC8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733906221</pqid></control><display><type>article</type><title>On what evidence-base do we recommend self-monitoring of blood glucose?</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Kolb, Hubert ; Kempf, Kerstin ; Martin, Stephan ; Stumvoll, Michael ; Landgraf, Rüdiger</creator><creatorcontrib>Kolb, Hubert ; Kempf, Kerstin ; Martin, Stephan ; Stumvoll, Michael ; Landgraf, Rüdiger</creatorcontrib><description>Abstract Self-monitoring of blood glucose (SMBG) has been considered one major breakthrough in diabetes therapy because, for the first time, patients were able to determine their blood glucose levels during daily life. It seems obvious that this must be of advantage to disease management and clinical outcome, but it has become a nightmare for those trying to provide evidence. Randomised controlled trials have yielded inconsistent results on a benefit of SMBG-based treatment strategies not only in type 2 but – surprisingly – also in type 1 and gestational diabetes. Despite this, SMBG is being considered indispensible in intensive insulin treatment, but is being debated for other clinical settings. When considering the non-RCT based reasons for recommending SMBG in type 1 and gestational diabetes it becomes apparent that the same reasons also apply to type 2 diabetes.</description><identifier>ISSN: 0168-8227</identifier><identifier>EISSN: 1872-8227</identifier><identifier>DOI: 10.1016/j.diabres.2009.10.014</identifier><identifier>PMID: 19926160</identifier><language>eng</language><publisher>Ireland: Elsevier Ireland Ltd</publisher><subject>Activities of Daily Living ; Blood Glucose Self-Monitoring - methods ; Diabetes Mellitus - blood ; Diabetes Mellitus - therapy ; Diabetes Mellitus, Type 1 - blood ; Diabetes Mellitus, Type 2 - blood ; Diabetes, Gestational - blood ; Endocrinology & Metabolism ; Evidence-Based Medicine ; Female ; Gestational diabetes ; Glycated Hemoglobin A - drug effects ; Glycated Hemoglobin A - metabolism ; HbA1c ; Humans ; Hypoglycaemia ; Pregnancy ; Randomized Controlled Trials as Topic ; Self-monitoring of blood glucose ; Type 1 diabetes ; Type 2 diabetes</subject><ispartof>Diabetes research and clinical practice, 2010-02, Vol.87 (2), p.150-156</ispartof><rights>Elsevier Ireland Ltd</rights><rights>2009 Elsevier Ireland Ltd</rights><rights>2009 Elsevier Ireland Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c419t-ca8f147390e28001809ca18d3f1246824801974ca618f59b10a03feaf2e758ae3</citedby><cites>FETCH-LOGICAL-c419t-ca8f147390e28001809ca18d3f1246824801974ca618f59b10a03feaf2e758ae3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.diabres.2009.10.014$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19926160$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kolb, Hubert</creatorcontrib><creatorcontrib>Kempf, Kerstin</creatorcontrib><creatorcontrib>Martin, Stephan</creatorcontrib><creatorcontrib>Stumvoll, Michael</creatorcontrib><creatorcontrib>Landgraf, Rüdiger</creatorcontrib><title>On what evidence-base do we recommend self-monitoring of blood glucose?</title><title>Diabetes research and clinical practice</title><addtitle>Diabetes Res Clin Pract</addtitle><description>Abstract Self-monitoring of blood glucose (SMBG) has been considered one major breakthrough in diabetes therapy because, for the first time, patients were able to determine their blood glucose levels during daily life. It seems obvious that this must be of advantage to disease management and clinical outcome, but it has become a nightmare for those trying to provide evidence. Randomised controlled trials have yielded inconsistent results on a benefit of SMBG-based treatment strategies not only in type 2 but – surprisingly – also in type 1 and gestational diabetes. Despite this, SMBG is being considered indispensible in intensive insulin treatment, but is being debated for other clinical settings. When considering the non-RCT based reasons for recommending SMBG in type 1 and gestational diabetes it becomes apparent that the same reasons also apply to type 2 diabetes.</description><subject>Activities of Daily Living</subject><subject>Blood Glucose Self-Monitoring - methods</subject><subject>Diabetes Mellitus - blood</subject><subject>Diabetes Mellitus - therapy</subject><subject>Diabetes Mellitus, Type 1 - blood</subject><subject>Diabetes Mellitus, Type 2 - blood</subject><subject>Diabetes, Gestational - blood</subject><subject>Endocrinology & Metabolism</subject><subject>Evidence-Based Medicine</subject><subject>Female</subject><subject>Gestational diabetes</subject><subject>Glycated Hemoglobin A - drug effects</subject><subject>Glycated Hemoglobin A - metabolism</subject><subject>HbA1c</subject><subject>Humans</subject><subject>Hypoglycaemia</subject><subject>Pregnancy</subject><subject>Randomized Controlled Trials as Topic</subject><subject>Self-monitoring of blood glucose</subject><subject>Type 1 diabetes</subject><subject>Type 2 diabetes</subject><issn>0168-8227</issn><issn>1872-8227</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkcFu1DAQhi0EareljwDyjVOWGSeb2BcqVEFBqtQDcLYce1y8JHGxk1Z9e5zuSkhcONkaffOP5hvG3iBsEbB9v9-6YPpEeSsAVKltAZsXbIOyE5UUonvJNoWTz_9TdpbzHgDautmdsFNUSrTYwoZd30788aeZOT0ER5OlqjeZuIv8kXgiG8eRJsczDb4a4xTmmMJ0x6Pn_RCj43fDYmOmy9fslTdDpovje85-fP70_epLdXN7_fXq401lG1RzZY302HS1AhISACUoa1C62qNoWikaCai6xpoWpd-pHsFA7cl4Qd1OGqrP2btD7n2KvxfKsx5DtjQMZqK4ZN3VJbsVAgu5O5A2xZwTeX2fwmjSk0bQq0K910eFelW4lovC0vf2OGHpR3J_u47OCnB5AKjs-RAo6WzDqs6FImzWLob_jvjwT4IdwhSsGX7RE-V9XNJUJGrUWWjQ39Y7rmcEBdC0QtZ_ANlHmC8</recordid><startdate>20100201</startdate><enddate>20100201</enddate><creator>Kolb, Hubert</creator><creator>Kempf, Kerstin</creator><creator>Martin, Stephan</creator><creator>Stumvoll, Michael</creator><creator>Landgraf, Rüdiger</creator><general>Elsevier Ireland Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20100201</creationdate><title>On what evidence-base do we recommend self-monitoring of blood glucose?</title><author>Kolb, Hubert ; Kempf, Kerstin ; Martin, Stephan ; Stumvoll, Michael ; Landgraf, Rüdiger</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c419t-ca8f147390e28001809ca18d3f1246824801974ca618f59b10a03feaf2e758ae3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Activities of Daily Living</topic><topic>Blood Glucose Self-Monitoring - methods</topic><topic>Diabetes Mellitus - blood</topic><topic>Diabetes Mellitus - therapy</topic><topic>Diabetes Mellitus, Type 1 - blood</topic><topic>Diabetes Mellitus, Type 2 - blood</topic><topic>Diabetes, Gestational - blood</topic><topic>Endocrinology & Metabolism</topic><topic>Evidence-Based Medicine</topic><topic>Female</topic><topic>Gestational diabetes</topic><topic>Glycated Hemoglobin A - drug effects</topic><topic>Glycated Hemoglobin A - metabolism</topic><topic>HbA1c</topic><topic>Humans</topic><topic>Hypoglycaemia</topic><topic>Pregnancy</topic><topic>Randomized Controlled Trials as Topic</topic><topic>Self-monitoring of blood glucose</topic><topic>Type 1 diabetes</topic><topic>Type 2 diabetes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kolb, Hubert</creatorcontrib><creatorcontrib>Kempf, Kerstin</creatorcontrib><creatorcontrib>Martin, Stephan</creatorcontrib><creatorcontrib>Stumvoll, Michael</creatorcontrib><creatorcontrib>Landgraf, Rüdiger</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetes research and clinical practice</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kolb, Hubert</au><au>Kempf, Kerstin</au><au>Martin, Stephan</au><au>Stumvoll, Michael</au><au>Landgraf, Rüdiger</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>On what evidence-base do we recommend self-monitoring of blood glucose?</atitle><jtitle>Diabetes research and clinical practice</jtitle><addtitle>Diabetes Res Clin Pract</addtitle><date>2010-02-01</date><risdate>2010</risdate><volume>87</volume><issue>2</issue><spage>150</spage><epage>156</epage><pages>150-156</pages><issn>0168-8227</issn><eissn>1872-8227</eissn><abstract>Abstract Self-monitoring of blood glucose (SMBG) has been considered one major breakthrough in diabetes therapy because, for the first time, patients were able to determine their blood glucose levels during daily life. It seems obvious that this must be of advantage to disease management and clinical outcome, but it has become a nightmare for those trying to provide evidence. Randomised controlled trials have yielded inconsistent results on a benefit of SMBG-based treatment strategies not only in type 2 but – surprisingly – also in type 1 and gestational diabetes. Despite this, SMBG is being considered indispensible in intensive insulin treatment, but is being debated for other clinical settings. When considering the non-RCT based reasons for recommending SMBG in type 1 and gestational diabetes it becomes apparent that the same reasons also apply to type 2 diabetes.</abstract><cop>Ireland</cop><pub>Elsevier Ireland Ltd</pub><pmid>19926160</pmid><doi>10.1016/j.diabres.2009.10.014</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0168-8227 |
| ispartof | Diabetes research and clinical practice, 2010-02, Vol.87 (2), p.150-156 |
| issn | 0168-8227 1872-8227 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_733906221 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete |
| subjects | Activities of Daily Living Blood Glucose Self-Monitoring - methods Diabetes Mellitus - blood Diabetes Mellitus - therapy Diabetes Mellitus, Type 1 - blood Diabetes Mellitus, Type 2 - blood Diabetes, Gestational - blood Endocrinology & Metabolism Evidence-Based Medicine Female Gestational diabetes Glycated Hemoglobin A - drug effects Glycated Hemoglobin A - metabolism HbA1c Humans Hypoglycaemia Pregnancy Randomized Controlled Trials as Topic Self-monitoring of blood glucose Type 1 diabetes Type 2 diabetes |
| title | On what evidence-base do we recommend self-monitoring of blood glucose? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T06%3A07%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=On%20what%20evidence-base%20do%20we%20recommend%20self-monitoring%20of%20blood%20glucose?&rft.jtitle=Diabetes%20research%20and%20clinical%20practice&rft.au=Kolb,%20Hubert&rft.date=2010-02-01&rft.volume=87&rft.issue=2&rft.spage=150&rft.epage=156&rft.pages=150-156&rft.issn=0168-8227&rft.eissn=1872-8227&rft_id=info:doi/10.1016/j.diabres.2009.10.014&rft_dat=%3Cproquest_cross%3E733906221%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733906221&rft_id=info:pmid/19926160&rft_els_id=S0168822709004628&rfr_iscdi=true |